Botulinum toxin in urology: evaluation using an evidence-based medicine approach
Christopher P Smith, George T Somogyi and Timothy B Boone*
Correspondence *Scott Department of Urology, Baylor College of Medicine, 6560 Fannin St, #2100, Houston, TX 77030, USA
Email tboone@bcm.tmc.edu
Botulinum toxin is under investigation as a treatment for a variety of urologic disorders. This evidence-based review objectively analyses the data on these off-label uses of botulinum toxin. Although most of the available data relates to uses in neurogenic bladder disorders, other applications in the bladder, urethra and prostate gland are discussed.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A role for nitric oxide synthase in urinary ?urge syndrome?Nature Medicine News and Views (01 May 1997)